AstraZeneca Vaccine Clinical Trial “Resumption Determined by Independent Committee” September 11, 5:40
k10012612051_202009110537_202009110540.mp4
British pharmaceutical giant AstraZeneca has decided that an independent committee will decide whether clinical trials of the temporarily suspended coronavirus vaccine can be resumed, and if the trials are resumed, it will become a vaccine. He said it would be clear by the end of the year whether it would work.
British pharmaceutical giant AstraZeneca is working with Oxford University to develop a vaccine for the new coronavirus, but said yesterday that it had temporarily suspended clinical trials to validate safety data. I am.
Solio CEO of AstraZeneca attended an online event on the 10th, explaining that it is not known at this time because an independent committee will decide whether clinical trials can be resumed, while clinical trials are in the process of vaccine development. He emphasized that temporary interruptions are common.
He added that if the trial resumes, "it will be clear by the end of the year whether the vaccine will work."
"I don't know if it's transverse myelitis," Sorio said in a statement that some media reported that people vaccinated in clinical trials had symptoms of transverse myelitis. I have to look it up. "
WHO Chief Scientist "Interruptions are common"
British pharmaceutical giant AstraZeneca is temporarily suspending clinical trials of vaccines, WHO = World Health Organization chief scientist Swaminasan said at a press conference on the 10th, "There are ups and downs in vaccine development. It may be a warning to let everyone know. Development isn't always fast and straightforward. Temporary interruptions are common and don't need to be overly discouraged. "
He added, "Safety is the number one priority for any clinical trial. The trial will be interrupted and the details of the person with side effects will be investigated." He said he would watch over the safety verification. ..